7x Winner of the MMIT Patient Choice Award!

Give us a call 855.726.8479 | 412.246.9858

PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the second quarter of 2021, PANTHERx obtained the highest Net Promoter Score (NPS) among all independent specialty pharmacies surveyed. Net Promoter Score (NPS) is compiled by asking patients, on a scale of 0 to 10, how likely they would be to recommend their specialty pharmacy to a friend or family member. With an NPS of 97 (out of 100), PANTHERx scored nearly 50% higher than the industry average.

“Our focus on rare and orphan diseases and our dedication to the people we serve has always driven PANTHERx, propelling us forward and motivating our success. Feedback is critical to our operations and receiving it straight from our patients, as provided by the MMIT Specialty Pharmacy Patient Satisfaction surveys, is invaluable. We strive to create the best possible experience for every person that PANTHERx serves. To know where we are excelling, or where improvements may be needed allows us to quantitatively assess our performance and progress quarter over quarter and year over year. We are proud to have earned such high marks from our patients and embrace the challenge of maintaining, even exceeding, our rank,” said Rob Snyder, President of PANTHERx Rare.

The PANTHERx team is honored to be held in such high regard by our patients. To know we are making a positive impact in the lives of so many is rewarding. Highlights from the recent survey include:

About PANTHERx Rare Pharmacy

PANTHERx, part of Envolve Pharmacy Solutions, is one of the largest and fastest growing rare pharmacies in the United States. PANTHERx transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to patients living with rare and devastating conditions. Although the overall incidence of rare diseases is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a three-time winner of the prestigious MMIT Patient Choice Award, including the 2020 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, and ACHC.